International Development Grant
Biological Threat Reduction through Vaccine Research and Development
Project Number: CA-3-P010319001
Status: Closed
Country/Region: Unknown
Regional Focus:
Maximum Contribution: $10,000,000.00
Start Date: March 24, 2021
End Date: April 30, 2023
Duration: 2.1 years
Project Description
This project aims to support the acceleration of the development of vaccines against priority emerging infectious diseases and enable access to these vaccines for affected populations during diseases outbreaks This would help to mitigate the threat from emerging infectious outbreaks whether naturally occurring or deliberately caused.
Expected Results
The expected outcomes of this project include: (1) improved preparedness of states to respond to emerging infectious diseases; and (2) improved sustainability of disease response solutions.
Progress & Results Achieved
Results achieved as of March 2023 include: (1) developed seven COVID-19 vaccine candidates (of which five have achieved licensure); (2) established three partnership agreements with vaccine manufacturers to develop and sustainably distribute vaccines against chikungunya to low-resource countries; and (3) distributed over 1.9 billion COVID-19 vaccine doses to low-resource countries.
Key Information
Executing Agency:
Coalition for Epidemic Preparedness
Reporting Organization:
Global Affairs Canada
Program:
YFMInternaAssistPartnershp&Programing Br
Last Modified:
September 19, 2025
Development Classifications
DAC Sector:
Aid Type: Core support to NGOs other private bodies PPPs and research institutes
Collaboration: Bilateral core contributions to NGOs and other private bodies / PPPs
Finance Type: Aid grant excluding debt reorganisation
Selection Mechanism:
Foreign Affairs and Trade Gs&Cs